B
BNTX
BIONTECH
92.08
+2.46+2.74%After Hours: 91.43 -0.65 -0.71%19:55 04/08 EDT
OPEN/PREV CLOSE92.45/89.62
TODAY RANGE90.95-92.50
VOL569.53K
MARKET CAP23.29B
52 WEEK RANGE79.52-124.00
AVG VOL (3M)1.16M
% TURNOVER0.23%
TURNOVER--
P/E (TTM)-16.6902
% RANGE1.73%
EPS(TTM)-5.5170
P/E(FORWARD)-18.8384
P/B1.026
BVPS89.78
DIVIDEND--
P/S6.87
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.91B
SHARES OUTSTANDING252.88M
NEXT EARNINGS--
FREE FLOAT107.67M
LOT SIZE1
EX-DATE06/02/2022
News
Press Releases
Financial Reports
Profile
Seeking Alpha·11h ago
RFK Jr. changes rules to select CDC vaccine advisors after legal setback
Simply Wall St·1d ago
Is BioNTech (BNTX) Quietly Rewriting Its Investment Story Around Oncology Beyond COVID Vaccines?
Benzinga·1d ago
Why Is Pfizer Stock Dropping Tuesday?
TipRanks·4d ago
BioNTech Earnings Call: Cash-Rich Pivot Beyond COVID
Simply Wall St·4d ago
Assessing BioNTech (NasdaqGS:BNTX) Valuation After Analyst Moves And COVID Vaccine Trial Setback
TipRanks·6d ago
Wells Fargo Issues a Buy Rating on BioNTech SE (BNTX)
Benzinga·04/01 17:56
Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat
Seeking Alpha·04/01 16:13
Pfizer, BioNTech end U.S. COVID vaccine trial over low enrollments; Reuters
Seeking Alpha·04/01 15:40
Belgian court orders Poland, Romania to accept $2.2B of Pfizer COVID shots
Simply Wall St·03/28 12:06
How New Lung Cancer Trial Data At BioNTech (BNTX) Has Changed Its Investment Story
Simply Wall St·03/27 09:12
BioNTech (NasdaqGS:BNTX) Valuation Check After New Lung Cancer Data Highlights Oncology Pipeline Progress
Seeking Alpha·03/25 20:24
White House misses deadline for CDC director nominee
Simply Wall St·03/25 17:04
BioNTech Lung Cancer Data Broadens Oncology Story Beyond Infectious Diseases
Same Industry
Name/Symbol
Change%
Price